[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

E-pharmacy Market: Segmented by Type (Over the Counter Drugs and Prescription Drugs); By Product (Skin Care, Dental, Cold & Flu, Weight Loss and Others); and Region – Global Analysis of Market Size, Share & Trends for 2019–2020 and Forecasts to 2030

May 2024 | 175 pages | ID: E192EF21F11CEN
Fatpos Global

US$ 5,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
178+ Pages Research Report Global E-pharmacy Market to surpass USD 174.87 billion by 2030 from USD 56.9 billion in 2020 at a CAGR of 16.24% in the coming years, i.e., 2021-30.

Product Overview
A pharmacy that operates over the internet and sends orders to customers by mail or shipping companies is known as an E-Pharmacy. The rise in the number of internet users expanded access to web-based and online resources, and the increasing use of e-prescriptions in hospitals and other healthcare settings are all contributing to the e-pharmacy market's growth.

Market Highlights
Global E-pharmacy market is expected to project a notable CAGR of 16.24% in 2030.
High acceptance of e-commerce, increased online orders, growth in the elderly population and rising implementation of e-prescriptions in hospitals and other healthcare services are all major factors driving the e-pharmacy market size. Furthermore, the recent outbreak of COVID-19 has had a significant impact on the use of online pharmacy sites, resulting in an increase in the size of the e-pharmacy industry.

Global E-pharmacy Market: Segments
Over the Counter, Drugs segment to grow with the highest CAGR during 2020-30
Global E-pharmacy market is segmented by type into Over-the-Counter Drugs and Prescription Drugs. In the year 2020, the Over the Counter Drugs segment dominated the industry. Over-the-counter medicines offer key medications for a wide variety of health problems, allowing patients to avoid hospital visits. As a result, increased public awareness and knowledge about the primary opioid treatment would spur demand growth. With an increase in dermal OTC product sales, the segment will expand as the prevalence of various dermatological conditions rises. Furthermore, the availability of OTC drugs will continue to increase consumer demand, resulting in increased sales for the market.

Weight Loss segment to grow with the highest CAGR during 2020-30
Global E-pharmacy market is divided by-products into Skin Care, Dental, Cold & Flu, Weight Loss, and Others. The E-pharmacy market is expected to expand rapidly in the Weight Loss product industry. Adults are becoming more interested in and prefer physical exercise. Furthermore, the demand for weight loss products among obese people to reduce the burden of associated health risks including high blood pressure, coronary heart disease, and osteoarthritis would affect product demand. As a result, consumer preference for online pharmacies will have a positive impact on industry growth in the coming years due to convenience and favorable services.

Market Dynamics
Drivers
Increasing internet penetration and change in consumer behavior
Some of the factors driving growth include increased internet penetration around the world, improved healthcare infrastructure, rapid population aging, and increased consumer knowledge of e-commerce. One of the main factors driving market growth is a change in consumer behavior, with an increased demand for convenience. In addition, the growing use of e-commerce and digital technology in the healthcare industry is expected to boost growth.

Rising COVID-19 outbreak and lockdown situations
The rising COVID-19 outbreak has increased demand for e-pharmacies, especially in areas where strict lockdown scenarios are in place and the number of COVID-19 patients is at an alarming rate. People living in these areas who have diseases other than COVID-19 need prescription supplies, and since patients are unable to leave their homes to buy drugs due to the lockout, e-pharmacy proves to be a successful option for meeting this demand.

Restraint
Increased competition and sale of unapproved medications
The industry is harmed by the existence of a large number of illegal e-pharmaceuticals around the world. These unlicensed pharmacies sell medications that have not been approved for sale. From these e-Pharmaceuticals, there is always the possibility of getting counterfeit and contaminated drugs with incorrect active ingredients.

Global E-pharmacy Market: Key Players
3M

Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis

ConvaTec Group Plc
Integra Lifesciences Holdings Corporation
Molnlycke Health Care AB
B. Braun Melsungen AG
Baxter International INC
Smith & Nephew Plc
Cardinal Health
Coloplast Corp
Other Prominent Players

Global E-pharmacy Market: Regions
Global E-pharmacy market is segmented based on regional analysis into five major regions. These include North America, Latin America, Europe, Asia Pacific, and the Middle East, and Africa. Global E-pharmacy in Europe held the largest market share in the year 2020 as a result of the growing use of internet-of-things (IoT). The growing number of internet users and the digitalization of the pharmaceutical industry would add to the regional value. Furthermore, the expanding e-commerce industry in European countries would boost business revenue. During the COVID-19 pandemic, customers' preference for at-home, timely services has provided enormous opportunities for e-pharmacies in the area.

Global E-pharmacy Market is further segmented by region into:
North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United States and Canada
Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil, and Rest of Latin America
Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey, and Rest of Europe
Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia, and Rest of APAC
Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa, and Rest of MENA

Global E-pharmacy Market report also contains analysis on:
E-pharmacy Market Segments:
By Type:
Over the Counter Drugs
Prescription Drugs
By Product
Skin Care
Dental
Cold & Flu
Weight Loss
Others
E-pharmacy Dynamics
E-pharmacy Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints

E-pharmacy Market Report Scope and Segmentation

Report Attribute Details
Market size value in 2020 USD 56.9 billion
Revenue forecast in 2030 USD 174.87 billion
Growth Rate CAGR of 16.24% from 2021 to 2030
Base year for estimation 2020
Quantitative units Revenue in USD million and CAGR from 2021 to 2030
Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered Type, product, and Region
Regional scope North America; Europe; Asia Pacific; Latin America; Middle East & Africa (MEA)
Key companies profiled 3M, ConvaTec Group Plc, Integra Lifesciences Holdings Corporation, Molnlycke Health Care AB, B. Braun Melsungen AG, Baxter International INC, Smith & Nephew Plc, Cardinal Health, Coloplast Corp., and other prominent players.

Frequently Asked Questions
How big is the E-pharmacy market?
What is the E-pharmacy market growth?
Which segment accounted for the largest E-pharmacy market share?
Who are the key players in the E-pharmacy market?
What are the factors driving the E-pharmacy market?
1. EXECUTIVE SUMMARY

2. GLOBAL E-PHARMACY MARKET

2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms

3. RESEARCH METHODOLOGY

3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation

4. AVERAGE PRICING ANALYSIS

5. MACRO-ECONOMIC INDICATORS

6. MARKET DYNAMICS

6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends

7. CORRELATION & REGRESSION ANALYSIS

7.1. Correlation Matrix
7.2. Regression Matrix

8. RECENT DEVELOPMENT, POLICIES & REGULATORY LANDSCAPE

9. RISK ANALYSIS

9.1. Demand Risk Analysis
9.2. Supply Risk Analysis

10. GLOBAL E-PHARMACY MARKET ANALYSIS

10.1. Porters Five Forces
  10.1.1. Threat of New Entrants
  10.1.2. Bargaining Power of Suppliers
  10.1.3. Threat of Substitutes
  10.1.4. Rivalry
10.2. PEST Analysis
  10.2.1. Political
  10.2.2. Economic
  10.2.3. Social
  10.2.4. Technological

11. GLOBAL E-PHARMACY MARKET

11.1. Market Size & forecast, 2020A-2030F
  11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F

12. GLOBAL E-PHARMACY MARKET: MARKET SEGMENTATION

12.1. By Regions
  12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2. By Type: Market Share (2020-2030F)
  12.2.1. Over the Counter Drugs, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.2.2. Prescription Drugs, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3. By Product: Market Share (2020-2030F)
  12.3.1. Skin Care, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.3.2. Dental, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.3.3. Cold & Flu, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.3.4. Weight Loss, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.3.5. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F

13. COMPANY PROFILE

13.1. 3M
  13.1.1. Company Overview
  13.1.2. Company Total Revenue (Financials)
  13.1.3. Market Potential
  13.1.4. Global Presence
  13.1.5. Key Performance Indicators
  13.1.6. SWOT Analysis
  13.1.7. Product Launch
13.2. ConvaTec Group Plc
13.3. Integra Lifesciences Holdings Corporation
13.4. Molnlycke Health Care AB
13.5. B. Braun Melsungen AG
13.6. Baxter International INC
13.7. Smith & Nephew Plc
13.8. Cardinal Health
13.9. Coloplast Corp
13.10. Other Prominent Players
Consultant Recommendation
**The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.


More Publications